Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Common Equity (2020 - 2025)

Historic Common Equity for Incannex Healthcare (IXHL) over the last 4 years, with Q3 2025 value amounting to $77.0 million.

  • Incannex Healthcare's Common Equity rose 106767.25% to $77.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.0 million, marking a year-over-year increase of 106767.25%. This contributed to the annual value of $13.4 million for FY2025, which is 1936.35% up from last year.
  • As of Q3 2025, Incannex Healthcare's Common Equity stood at $77.0 million, which was up 106767.25% from $13.4 million recorded in Q2 2025.
  • Over the past 5 years, Incannex Healthcare's Common Equity peaked at $77.0 million during Q3 2025, and registered a low of $965000.0 during Q4 2024.
  • Its 3-year average for Common Equity is $18.7 million, with a median of $12.3 million in 2024.
  • In the last 5 years, Incannex Healthcare's Common Equity tumbled by 9488.66% in 2024 and then surged by 106767.25% in 2025.
  • Incannex Healthcare's Common Equity (Quarter) stood at $18.9 million in 2023, then crashed by 94.89% to $965000.0 in 2024, then soared by 7880.1% to $77.0 million in 2025.
  • Its Common Equity was $77.0 million in Q3 2025, compared to $13.4 million in Q2 2025 and $7.4 million in Q1 2025.